Even before the new tariffs, many people have found the medications to be prohibitively expensive. Without insurance, they ...

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Cosmetic surgeons are seeing a new wave of patients seeking treatment for "Ozempic face" - the sagging, hollow appearance ...

Novo Nordisk A/S (NYSE:NVO), the Danish pharmaceutical giant renowned for its weight-loss drug Wegovy and diabetes treatment ...

TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Wegovy’s primary purpose is a weight-loss medication, while Ozempic can improve blood sugar in those living with type 2 diabetes in addition to weight loss, Megan Warnke, RDN, CDCES, tells us.